Objectives: To study the clonality of gentamicin-resistant, extended-spectrum b-lactamase (ESBL)-negative and ESBL-producing Escherichia coli isolated from community-onset urinary tract infections (UTIs) in Cornwall.
Introduction
Multiresistant Escherichia coli strains from community-onset infections are an increasing public health concern, especially those with CTX-M extended-spectrum b-lactamases (ESBLs). 1 In the UK, 90% of CTX-M-producing E. coli produce group 1 enzymes (mainly CTX-M-15) and PFGE analysis of a national collection has defined five major strains. 1 The local epidemiology of E. coli producing CTX-M enzymes may, however, differ from this national picture with, for example, dominance of different strains, or higher prevalence of those with group 9 CTX-M enzymes.
In Cornwall (the south-west peninsula of England), concern was raised over the emergence of gentamicin-resistant E. coli isolates recovered from urines of patients attending general practice. Gentamicin is rarely prescribed in such settings. Several, but not all of these resistant isolates were ESBL producers. We therefore studied the clonality of gentamicin-resistant, ESBL-negative isolates from urines of patients attending general practitioners (GPs) ESBL-producing E. coli, many also gentamicin-resistant and also isolated from GP urines. 
Materials and methods

Bacterial isolates and initial susceptibility testing
Investigation in the reference laboratories
MICs were determined and interpreted using BSAC methodology, 2 and bla CTX-M genes were sought by multiplex PCR. 3 Selected isolates were compared by PFGE of XbaI-digested genomic DNA, and banding patterns were analysed using BioNumerics software (Applied Maths, Sint-Martens-Latem, Belgium).
Investigation of an outbreak strain
The clinical notes for selected patients were analysed to determine any obvious common factors associated with acquisition of a PFGE-defined outbreak strain.
Results and discussion
Reference investigations and recognition of a 'Cornish outbreak' strain During 2004-2005, the reference laboratories received 69 E. coli isolates from Truro (Cornwall) laboratory for inclusion in this study. These included: 14 gentamicin-resistant, ESBL-negative isolates; 45 with group 1 CTX-M enzymes; seven with group 9 CTX-M enzymes and three with non-CTX-M ESBLs.
All 14 ESBL-negative isolates, and 16 ESBL-producing isolates dating from 2004, were compared by PFGE ( Figure 1 ). Nine gentamicin-resistant, ESBL-negative isolates were distinct (<85% similarity) from the ESBL producers, but three were related to isolates with CTX-M group 1 enzymes, and two isolates from one patient were related to an isolate with a non-CTX-M ESBL.
One major outbreak strain was identified, and comprised 11 gentamicin-resistant and one gentamicin-susceptible CTX-M group 1 producers and two gentamicin-resistant, ESBL-negative isolates (12 of these are shown in Figure 1) ; the 14 isolates were from nine patients. This 'Cornish outbreak' strain was distinct by PFGE from five nationally distributed CTX-M-producing strains, including the UK epidemic strain A (Figure 1) , 1 which accounted for only three of the 69 E. coli isolates referred from Truro laboratory.
Geometric mean MICs for the 'Cornish outbreak' strain are shown in Table 1 . CTX-M ESBL-producing isolates of this strain were resistant to penicillins, all cephalosporins tested (but with potentiation by clavulanate), and also to ciprofloxacin, gentamicin and tobramycin. Isolates of the outbreak strain were susceptible to piperacillin/tazobactam, amikacin and carbapenems.
Two gentamicin-resistant, ESBL-negative isolates (unrelated by PFGE and distinct from the 'Cornish outbreak' strain) were highly resistant to the veterinary aminoglycoside apramycin (MICs > 512 mg/L), which is consistent with AAC(3)-IV activity;
4 the range of apramycin MICs for all other isolates was 2-32 mg/L.
Analysis of case notes
Recognition of the 'Cornish outbreak' strain was unexpected and prompted analysis of clinical notes for the nine patients (5 male and 4 female) affected to determine any obvious common factors that might be associated with its acquisition. The average age of these patients was 80 years (range, 57-93 years).
One patient developed a hospital-acquired bacteraemia (defined as onset >48 h after admission) with the 'Cornish outbreak' strain while an inpatient on ward G of a local hospital (RCH) in March to May 2004 during a cluster of infections on this ward caused by ESBL-producing E. coli. This blood culture isolate was the only saved representative from the ward cluster. The other eight patients infected by the 'Cornish outbreak' strain had presented at various GP surgeries, separated by up to 30 miles. The strain was isolated from urine in eight patients, from sputum in three, from a peg site in one, and two patients were widely colonized. Despite the community-onset of their UTIs, seven of these eight patients had prior, and in some instances multiple, hospital inpatient admissions, and multiple transfers between wards. The eighth only attended an outpatient clinic. The average time after hospital discharge before presentation with a UTI at their GP's surgery was 39 days (range 6-89 days). Mortality was not directly attributable to the ESBL-producing strain in five cases, but the sixth died with ESBL-producing E. coli septicaemia, implying causality.
These data suggest that the 'Cornish outbreak' strain may have caused the cluster of infections on ward G at RCH during March-May 2004, although only one isolate was available for testing. The alarming finding of a CTX-M-producing E. coli strain presenting in the community, but that could be traced to a hospital source led to a rapid review of susceptibility testing of all 'coliforms' in the clinical laboratory, as advocated previously, 1, 5 and methodology for detecting ESBLs was in place within two months of these findings.
In summary, most gentamicin-resistant, ESBL-negative isolates from community-onset UTIs in Cornwall were diverse and were distinct from ESBL-producing E. coli from communityonset UTIs. However, two ESBL-negative, gentamicin-resistant isolates were closely related to a local CTX-M-producing and gentamicin-resistant outbreak strain, suggesting gain or loss of H044640145  H043020213  H043060131  H044000221  H044180496  H044180497  H044500248  H042940047  H043460165  H043780513  H044440334  H043820039  H043840148  H043900130  H044180489  H044180493  H044780310  H044180486  H044180495  H041920299  H044180487  H044180488  H044180494  H043980259  H043980260  H044180490  H044180498  H044180499 H044180492 >32  1  >32  >32  >32  >32  >32  >32  >32  >32  >32  1  16  8  1  >32  >32  >32  >32  >32  >32  16  >32  >32  >32  >32 the bla CTX-M gene or a plasmid carrying it. Most of the patients infected by this outbreak strain had hospital admissions in the three months prior to onset of their UTIs. This has been identified previously as a risk factor for infections caused by ESBL producers in non-hospitalized patients. 6, 7 Old age (>60 years), as seen in patients described here, is also a known risk factor. 6 Although manifesting in the community, many of the UTIs of these Cornish patients appeared to have their origins in local hospitals and did not represent genuine community acquisition. This study highlights weaknesses in the concept of a clear distinction between hospital-and community-acquired infections caused by CTX-M-producing and other multiresistant E. coli. Clearly, acquisition in hospital may be followed by a period of colonization, which may be prolonged in some instances, prior to infection. Screening for faecal colonization at discharge, especially during on-going hospital clusters with ESBL-producing strains, would identify those patients most at risk of developing subsequent community-onset infections with multiresistant strains. Two non-CTX-M-producing isolates of the outbreak strain were excluded from this analysis.
